Similar articles

• Effects of antirheumatic drugs on endogenous arachidonate metabolism and chemotaxis in human neutrophil granulocytes.

  Nielsen OH, Ahnfelt-Rønne I, Elmgreen J. Nielsen OH, et al. Agents Actions. 1989 Jan;26(1-2):233-4. doi: 10.1007/BF02126622. Agents Actions. 1989. PMID: 2496592 No abstract available.
• The mode of action of anti-inflammatory drugs.

  Vane JR, Botting RM. Vane JR, et al. Postgrad Med J. 1990;66 Suppl 4:S2-17. Postgrad Med J. 1990. PMID: 2126623 Review.
• [Non-steroidal anti-inflammatory drugs. Suppression of biological response and non-steroidal anti-inflammatory drugs].

  Nishikawa M, Shirakawa S, Hidaka H. Nishikawa M, et al. Nihon Rinsho. 1987 May;45(5):1093-101. Nihon Rinsho. 1987. PMID: 3306016 Review. Japanese. No abstract available.
• Clinical pharmacology and use of nonsteroidal anti-inflammatory drugs.

  Mortensen ME, Rennebohm RM. Mortensen ME, et al. Pediatr Clin North Am. 1989 Oct;36(5):1113-39. doi: 10.1016/s0031-3955(16)36761-x. Pediatr Clin North Am. 1989. PMID: 2508045 Review.
• Inhibitory effects of methyl 7-butyl-4,5,6,7-tetrahydro-3-methylamino-4,6-dioxo-5-propyl- 2H-pyrazolo[3,4-d]pyrimidine-2-carboxylate (AA-2379) on lysosomal enzyme and arachidonic acid release from rat polymorphonuclear leukocytes and its mode of action.

  Makino H, Saijo T, Maki Y. Makino H, et al. Agents Actions. 1989 Nov;28(3-4):248-55. doi: 10.1007/BF01967411. Agents Actions. 1989. PMID: 2556899